Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BRISTOL MYERS SQUIBB CO Logo
A global biopharmaceutical company that discovers, develops, and commercializes medicines.
United States of America
BMY
An R&D-focused company developing drugs for CNS disorders and oncology.
South Korea
003000
C4 Therapeutics, Inc. Logo
Clinical-stage biopharma developing targeted protein degradation therapeutics.
United States of America
CCCC
Cadrenal Therapeutics, Inc. Logo
A late-stage biopharmaceutical company developing novel anticoagulation therapeutics.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for acute inflammatory and immunologic diseases.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops stem cell platforms to deliver oncolytic viruses for cancer therapy.
United States of America
CLDI
Calliditas Therapeutics Logo
Biopharma company developing and commercializing treatments for rare diseases.
Sweden
CALTX
CALTH. Inc Logo
Develops in vitro diagnostic tools for point-of-care and self-testing.
South Korea
402420
Cambrex Logo
A CDMO providing drug substance, drug product, and analytical services.
United States of America
CBM
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.